Response to letter regarding article, "plasmin cleavage of von willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy"

Circulation. 2015 Jan 13;131(2):e19-20. doi: 10.1161/CIRCULATIONAHA.114.012802.

Affiliations

¹ Laboratory of Clinical Chemistry and Haematology, Laboratory of Experimental Cardiology, UMC Utrecht, Utrecht, The Netherlands.
² Laboratory of Clinical Chemistry and Haematology, UMC Utrecht, Utrecht, The Netherlands.
³ Laboratory for Thrombosis Research, IRF Life Sciences, KU Leuven Kulak, Kortrijk, Belgium.
⁴ Laboratory of Experimental Cardiology, UMC Utrecht, Utrecht, The Netherlands.

PMID: 25583061
DOI: 10.1161/CIRCULATIONAHA.114.012802

No abstract available

Publication types

Letter
Comment

MeSH terms

ADAM Proteins / metabolism*
Animals
Fibrinolysin / metabolism*
Fibrinolysis / physiology*
Humans
Thrombotic Microangiopathies / metabolism*
von Willebrand Factor / metabolism*

Substances

von Willebrand Factor
Fibrinolysin
ADAM Proteins